# OnCo record arhgap5 (target). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/targets/arhgap5/>
  a schema:BioChemEntity ;
  onco:kind "target" ;
  schema:identifier "arhgap5" ;
  schema:name "ARHGAP5"@en ;
  schema:alternateName "Rho GTPase activating protein 5"@en, "Rho GTPase-activating protein 5"@en, "RhoGAP5"@en, "p190-B"@en, "p190BRhoGAP"@en, "GFI2"@en, "ARHGAP5" ;
  schema:description "ARHGAP5 (Rho GTPase-activating protein 5) is a gene whose normal job is to hold cell growth in check. The public catalogues list it as an oncogene driver and a tumour suppressor, and it is called a cancer driver by mutation analysis of patient cohorts. Tied to Bladder & urothelial cancer, Multiple myeloma, Pancreatic ductal adenocarcinoma and 4 more."@en ;
  schema:url <https://onco.cc/targets/arhgap5/> ;
  schema:dateModified "2026-09-23"^^xsd:date ;
  schema:citation <https://www.genenames.org/data/gene-symbol-report/#!/hgnc_id/HGNC:675>, <https://www.uniprot.org/uniprotkb/Q13017/entry>, <https://www.ncbi.nlm.nih.gov/gene/394>, <https://www.ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000100852> ;
  onco:tag "cancer-genes-wave" ;
  onco:targetClass "tumor-suppressor" ;
  schema:sameAs <https://www.genenames.org/data/gene-symbol-report/#!/hgnc_id/HGNC:675>, <https://www.ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000100852>, <https://www.uniprot.org/uniprotkb/Q13017/entry>, <https://www.ncbi.nlm.nih.gov/gene/394> ;
  onco:related <https://onco.cc/collections/intogen/> ;
  onco:cancers <https://onco.cc/cancers/urothelial/>, <https://onco.cc/cancers/multiple-myeloma/>, <https://onco.cc/cancers/pancreatic/>, <https://onco.cc/cancers/mesothelioma/>, <https://onco.cc/cancers/thyroid/>, <https://onco.cc/cancers/pleural-mesothelioma/>, <https://onco.cc/cancers/papillary-thyroid-cancer/> .
